Literature DB >> 29373771

[Estimation of underreporting of Chikungunya virus infection cases in Girardot, Colombia, from November, 2014, to May, 2015].

Óscar Pacheco1, Máncel Martínez, Ángela Alarcón, Mauricio Bonilla, Alexandra Caycedo, Tania Valbuena, Angie Zabaleta.   

Abstract

INTRODUCTION: Chikungunya virus infection in Colombia became epidemic in 2015. It is estimated that there is underreporting of cases to the public health surveillance system which can induce bias in epidemiological projections for decision making, a serious problem, as it veils the real magnitude and actual epidemiological importance of this disease.
OBJECTIVE: To estimate the underreporting of cases of chikungunya infection in the municipality of Girardot, Cundinamarca, from November, 2014, to May, 2015.
MATERIALS AND METHODS: We conducted a descriptive and retrospective study using surveys in 132 blocks selected by simple random sampling for community active search and the revision of 100% of the individual records of health services and those from the public health surveillance system for institutional active search. The data were analyzed using EpiInfo, version 7.
RESULTS: The attack rate was 64.7%. The estimated underreporting was 36.1% for not attending medical consultation while 24.9% of cases were not reported to the public health surveillance system. The principal cause for not seeking medical consultation among those surveyed (n=392; 43%) was self-medication, followed by the collapse of health services (n=207; 23%).
RESULTS: The attack rate was 64.7%. The estimated underreporting was 36.1% for not attending medical consultation while 24.9% of cases were not reported to the public health surveillance system. The principal cause for not seeking medical consultation among those surveyed (n=392; 43%) was self-medication, followed by the collapse of health services (n=207; 23%).
CONCLUSION: The overall underreporting since the beginning of the epidemic in Girardot was 87.05%.This research explains 60.9% of this underreporting.

Entities:  

Keywords:  Aedes aegypti; Chikungunya virus; Colombia.; diseases registries; epidemiological surveillance

Mesh:

Year:  2017        PMID: 29373771     DOI: 10.7705/biomedica.v37i4.3370

Source DB:  PubMed          Journal:  Biomedica        ISSN: 0120-4157            Impact factor:   0.935


  4 in total

1.  Demographic and clinical characteristics of chikungunya patients from six Colombian cities, 2014-2015.

Authors:  Juan C Rueda; Ana M Santos; Jose-Ignacio Angarita; Rodrigo B Giraldo; Eugenia-Lucia Saldarriaga; Jesús Giovanny Ballesteros Muñoz; Elías Forero; Hugo Valencia; Francisco Somoza; Daniel Martin-Arsanios; Elias-Josué Quintero; Viviana Reyes-Martinez; Diana Padilla; Francy M Cuervo; Ingris Peláez-Ballestas; Mario H Cardiel; Paula X Pavía; John Londono
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

2.  A Chikungunya Virus Multiepitope Recombinant Protein Expressed from the Binary System Insect Cell/Recombinant Baculovirus Is Useful for Laboratorial Diagnosis of Chikungunya.

Authors:  Leonardo Assis da Silva; Monique da Rocha Queiroz Lima; Brenda Rabello de Camargo; Dyeferson Kened da Silva Coelho Guimarães; Anabele Azevedo Lima Barbastefano; Raquel Curtinhas de Lima; Paulo Vieira Damasco; Rivaldo Venâncio da Cunha; Luiz José de Souza; Elzinandes Leal de Azeredo; Luzia Maria de-Oliveira-Pinto; Tatsuya Nagata; Daniel M P Ardisson-Araújo; Flavia Barreto Dos Santos; Bergmann Morais Ribeiro
Journal:  Microorganisms       Date:  2022-07-18

3.  Cost-effectiveness analysis of VECTOS software for the control of diseases transmitted by Aedes aegypti in two Colombian municipalities

Authors:  Manuel Alejandro Salinas; Victoria Eugenia Soto; Sergio Iván Prada
Journal:  Biomedica       Date:  2020-06-15       Impact factor: 0.935

4.  Spatial and temporal invasion dynamics of the 2014-2017 Zika and chikungunya epidemics in Colombia.

Authors:  Kelly Charniga; Zulma M Cucunubá; Marcela Mercado; Franklyn Prieto; Martha Ospina; Pierre Nouvellet; Christl A Donnelly
Journal:  PLoS Comput Biol       Date:  2021-07-02       Impact factor: 4.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.